REG - Surgical Innovations - Future board change

Surgical InnovationsAnnouncement

07/01/2021 07:01

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20210107:nRSG8400Ka&default-theme=true

RNS Number : 8400K  Surgical Innovations Group PLC  07 January 2021

Surgical Innovations Group plc
("Surgical Innovations", "SI" or the "Company")

 

Future board change

 

Surgical Innovations Group plc (AIM: SUN) the designer, manufacturer and
distributor of innovative medical technology for minimally invasive surgery
("MIS"), announces that Adam Power, Group Development Director, has provided
twelve months' notice to the Board that he wishes to retire from his executive
role as Group Development Director, with effect from 31 December 2021.  The
current intention is that he will subsequently continue to serve as a
Non-executive Director for a further twelve months until 31 December 2022.

 

Commenting on the transition, Nigel Rogers, the Company's Chairman, said: "We
are grateful to Adam for both his past and continuing commitment.  These
arrangements ensure that Adam can continue to devote his full commitment to
current sales activities and supporting strategic business development, whilst
allowing the Company sufficient time to manage a smooth transition in his
Board and executive responsibilities."

 

 

For further information please contact:

 

 Surgical Innovations Group plc                       www sigroupplc com (http://www.sigroupplc.com/)
 David Marsh, CEO                                     Tel: 0113 230 7597
 Charmaine Day, Co Sec & GFC

 N+1 Singer (Nominated Adviser & Broker)              Tel: 020 7496 3000
 Aubrey Powell (Corporate Finance)
 Rachel Hayes (Corporate Broking)

 Walbrook PR (Financial PR & Investor Relations)      Tel: 020 7933 8780 or si@walbrookpr.com (mailto:si@walbrookpr.com)
 Paul McManus / Lianne Cawthorne                      Mob: 07980 541 893 / 07584 391 303

 

This announcement contains inside information for the purposes of Article 7 of
Regulation (EU) No 596/2014.

 

 

About Surgical Innovations Group plc

The Group specialises in the design, manufacture, sale and distribution of
innovative, high quality medical products, primarily for use in minimally
invasive surgery. Our product and business development is guided and supported
by a key group of nationally and internationally renowned surgeons across the
spectrum of minimally invasive surgical activity.

 

We design and manufacture and source our branded port access systems, surgical
instruments and retraction devices which are sold directly in the UK home
market through our subsidiary, Elemental Healthcare, and exported widely
through a global network of trusted distribution partners. Many of our
products in this field are based on a "resposable" concept, in which the
products are part re-usable, part disposable, offering a high quality and
environmentally responsible solution at a cost that is competitive against
fully disposable alternatives.

 

Elemental also has exclusive UK distribution for a select group of specialist
products employed in laparoscopy, bariatric and metabolic surgery, hernia
repair and breast reconstruction.

In addition, we design and develop medical devices for carefully selected OEM
partners, and have also collaborated with a major UK industrial partner to
provide precision engineering solutions to complex problems outside the
medical arena.

 

We aim for our brands to be recognised and respected by healthcare
professionals in all major geographical markets in which we operate and
provide by development, partnership or acquisition a broad portfolio of cost
effective, procedure specific surgical instruments and implantable devices
that offer reliable solutions to genuine clinical needs in the operating
theatre environment.

 

The Group currently employs approximately 100 people across two sites in the
UK.  Product design, engineering and manufacturing are carried out at the SI
site in Yorkshire. Commercial activities including marketing, UK distribution
and international sales and marketing are based at Elemental Healthcare in
Berkshire.

 

Further information

Further details of the Group's businesses are available on the following
websites:

www.sigroupplc.com (http://www.sigroupplc.com/)

www.surginno.com (http://www.surginno.com/)

www.elementalhealthcare.co.uk (http://www.elementalhealthcare.co.uk/)

To receive regular updates by email, please contact si@walbrookpr.com
(mailto:si@walbrookpr.com) .

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOAEAXFKELKFEFA